Despite wide dose ranges tested (6 g/kg to 20 mg/kg), multiple administration routes (intramuscular, intraperitoneal, intravenous, oral), and varied dosing frequencies across numerous animal models, no acute lethal dose has been identified
Clinical-Grade Internal Radiance Protocol
Patients seeking GLP-1 therapy should consult their healthcare provider about FDA-approved injectable or oral formulations and proper administration techniques for those products
Mechanisms / How It Works Retatrutide is a triple-agonist peptide , meaning it acts on GLP-1, GIP, and glucagon receptors simultaneously
By slowing gastric emptying, it reduces the time stomach acid has to work on B12-protein bonds
There is no evidence to suggest that tirzepatide should be discontinued solely due to throat discomfort unless directed by your healthcare provider